Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 3546 entries
View as:

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00558103 Org: User:
Start: 12/31/07 End: 12/31/11 Due: 12/31/12

SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00364429 Org: User:
Start: 07/31/05 End: 07/31/05 Due: 07/31/06

Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693

Phase: N/A Priority: Normal
NCT ID: NCT00493818 Org: User:
Start: 04/30/07 End: 06/30/08 Due: 06/30/09

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00951041 Org: User:
Start: 08/11/09 End: 08/30/10 Due: 08/30/11

A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT00108095 Org: User:
Start: 10/31/04 End: 08/31/05 Due: 08/31/06

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Phase: N/A Priority: Normal
NCT ID: NCT01938482 Org: User:
Start: 10/31/13 End: 02/17/15 Due: 02/17/16

Pharmacokinetic Study to Compare Two Formulations of Paracetamol

Phase: N/A Priority: Normal
NCT ID: NCT01767428 Org: User:
Start: 04/30/10 End: 04/30/10 Due: 04/30/11

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00374322 Org: User:
Start: 08/31/06 End: 07/31/13 Due: 07/31/14

Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00137917 Org: User:
Start: 07/31/02 End: 06/30/03 Due: 06/30/04

Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01827631 Org: User:
Start: 05/27/13 End: 06/25/13 Due: 06/25/14

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT01627327 Org: User:
Start: 04/01/12 End: 12/21/12 Due: 12/21/13

Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis

Phase: N/A Priority: Normal
NCT ID: NCT01978223 Org: User:
Start: 12/31/14 End: 12/31/15 Due: 12/31/16

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Phase: N/A Priority: Normal
NCT ID: NCT03688620 Org: User:
Start: 10/05/18 End: 01/04/19 Due: 01/04/20

Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00246701 Org: User:
Start: 11/01/05 End: 06/01/06 Due: 06/01/07

Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)

Phase: N/A Priority: Normal
NCT ID: NCT01390922 Org: User:
Start: 08/31/11 End: 10/31/14 Due: 10/31/15

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01966445 Org: User:
Start: 11/26/13 End: 09/18/17 Due: 09/18/18

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

Phase: N/A Priority: Normal
NCT ID: NCT00778895 Org: User:
Start: 11/10/08 End: 08/19/09 Due: 08/19/10

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00119171 Org: User:
Start: 11/30/04 End: - Due: -

Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00536679 Org: User:
Start: 09/20/07 End: 11/05/07 Due: 11/05/08

Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease

Phase: N/A Priority: Normal
NCT ID: NCT00699764 Org: User:
Start: 03/31/96 End: 10/31/99 Due: 10/31/00

The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00347360 Org: User:
Start: 07/31/06 End: 04/30/08 Due: 04/30/09

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Phase: N/A Priority: Normal
NCT ID: NCT01788228 Org: User:
Start: 03/22/13 End: 02/25/15 Due: 02/25/16

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01431963 Org: User:
Start: 09/30/11 End: 10/31/14 Due: 10/31/15

GSK2251052 in Complicated Urinary Tract Infection

Phase: N/A Priority: Normal
NCT ID: NCT01381549 Org: User:
Start: 06/28/11 End: 03/06/12 Due: 03/06/13

Drug Use Investigation for XYZAL®

Phase: N/A Priority: Normal
NCT ID: NCT01445262 Org: User:
Start: 02/28/11 End: 12/31/13 Due: 12/31/14